Literature DB >> 15124504

Health plan policies and programs for colorectal cancer screening: a national profile.

Carrie N Klabunde1, Gerald F Riley, Margaret T Mandelson, Paul S Frame, Martin L Brown.   

Abstract

BACKGROUND: A consensus has emerged that average-risk adults 50 years of age or older should be screened for colorectal cancer (CRC).
OBJECTIVES: To describe health plans' coverage policies, guidelines, and organized programs to promote CRC screening. STUDY DESIGN AND METHODS: Review of data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices, administered to a national sample of health plans in 1999-2000. The survey inquired about coverage policies for fecal occult blood testing, sigmoidoscopy, colonoscopy, and double-contrast barium enema; the nature of any guidelines the plan had issued to its providers on CRC screening; and systems for recruiting patients into screening and for tracking and reporting the results of screening and follow-up procedures.
RESULTS: Of 346 eligible health plans, 180 (52%) responded. Nearly all health plans covered at least 1 CRC screening modality. Plans were most likely to cover fecal occult blood testing (97%) and least likely to cover colonoscopy (57%). Sixty-five percent had issued guidelines on CRC screening to providers. One quarter had a mechanism to remind patients that they are due for CRC screening, but fewer had systems for prompting providers, contacting noncompliant patients, or tracking completion of screening.
CONCLUSIONS: Health plans have the ability to provide organizational infrastructure for a broad range of preventive services to well-defined populations. However, few health plans had all 3 essential CRC screening delivery components--coverage, guidelines, and tracking systems--in place in 1999-2000.

Entities:  

Mesh:

Year:  2004        PMID: 15124504

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  28 in total

1.  Modestly increased use of colonoscopy when copayments are waived.

Authors:  Shabnam Khatami; Lei Xuan; Rolando Roman; Song Zhang; Charles McConnel; Ethan A Halm; Samir Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2012-03-05       Impact factor: 11.382

Review 2.  Interventions to improve follow-up of abnormal findings in cancer screening.

Authors:  Roshan Bastani; K Robin Yabroff; Ronald E Myers; Beth Glenn
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

3.  Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay.

Authors:  Julia R Trosman; Stephanie L Van Bebber; Kathryn A Phillips
Journal:  J Oncol Pract       Date:  2010-09       Impact factor: 3.840

4.  Influence of health insurance coverage on breast, cervical, and colorectal cancer screening in rural primary care settings.

Authors:  Patricia A Carney; Jean O'Malley; David I Buckley; Motomi Mori; David A Lieberman; Lyle J Fagnan; James Wallace; Betty Liu; Cynthia Morris
Journal:  Cancer       Date:  2012-05-30       Impact factor: 6.860

5.  Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time.

Authors:  Chyke A Doubeni; Adeyinka O Laiyemo; Angela C Young; Carrie N Klabunde; George Reed; Terry S Field; Robert H Fletcher
Journal:  Ann Fam Med       Date:  2010 Jul-Aug       Impact factor: 5.166

6.  Mandated coverage of preventive care and reduction in disparities: evidence from colorectal cancer screening.

Authors:  Mary K Hamman; Kandice A Kapinos
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

7.  Lessons from state mandates of preventive cancer screenings.

Authors:  Wendy Yi Xu; Bryan Dowd; Jean Abraham
Journal:  Eur J Health Econ       Date:  2015-03-15

8.  Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates.

Authors:  Jennifer K Coury; Jennifer L Schneider; Beverly B Green; Laura-Mae Baldwin; Amanda F Petrik; Jennifer S Rivelli; Malaika R Schwartz; Gloria D Coronado
Journal:  Transl Behav Med       Date:  2020-02-03       Impact factor: 3.046

9.  Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial.

Authors:  Thomas D Sequist; Alan M Zaslavsky; Richard Marshall; Robert H Fletcher; John Z Ayanian
Journal:  Arch Intern Med       Date:  2009-02-23

10.  Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.

Authors:  Hardeep Singh; Himabindu Kadiyala; Gayathri Bhagwath; Anila Shethia; Hashem El-Serag; Annette Walder; Maria E Velez; Laura A Petersen
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.